Steno Type 1 Risk Engine predicts substantial reduction in risks for CVD, ESKD with SGLT2i as adjunct therapy for type 1 diabetes

Randomized, open-label, phase 3 trials conducted in patients with chronic kidney disease undergoing, not undergoing dialysis

Those with diabetes and a-fib have worse quality of life and more cardiac and neurological morbidities than those without diabetes

Weight loss at 12 months similar with intermittent or continuous energy restriction, but high dropout rate limits interpretation of study results

Findings significant for adults, but not pediatric subgroups

For the first time, the measure would enable the federal government to negotiate prices for medications covered by Medicare

Factors associated with remission included older age, HbA1c, weight loss from diagnosis to 2019, previous bariatric surgery

In all communities, relative density of fast-food restaurants linked to modestly increased risk for type 2 diabetes

Patients with small fiber neuropathy did not self-identify as disabled, but many have multiple comorbidities

Patients receiving attenuated adenovirus vaccine more likely to have no seroconversion, no detectable or diminished IgG response